EMA To Beef Up Guidance On Additional Risk Minimization Tools

 
• By Vibha Sharma

Based on its experience of reviewing tools used by companies for additional risk minimization, the European Medicines Agency is planning to update its guidance on this topic with more information on how these tools can be better employed.

SideEffects
Additional Risk Minimization Is Needed When Routine Measures Are Insufficient • Source: Shutterstock

More from Drug Safety

More from Pink Sheet